Adverse Drug Events: Substantial Problem but Magnitude Uncertain

Open Access

Abstract

Testimony issued by the General Accounting Office with an abstract that begins "Pursuant to a congressional request, GAO discussed its report on adverse drug events (ADE), focusing on the: (1) different types and causes of ADEs; (2) evidence on the overall incidence and cost of ADEs in the United States; and (3) measures that have been proposed to reduce the number and severity of ADEs."